VeinWay Closes Oversubscribed SAFE Round and Begins Series A Round
Or Yehuda, Israel, September 7, 2023 — VeinWay has closed an oversubscribed SAFE round of […]
Or Yehuda, Israel, September 7, 2023 — VeinWay has closed an oversubscribed SAFE round of […]
Details of first two clinical compassionate use cases presented at LINC in Leipzig, Germany ARNSBERG-HÜSTEN, Germany and OR […]
Ann Arbor, Michigan and Or Yehuda, Israel, March 2, 2023 — In a first-in-human, compassionate use case approved by the U.S. Food and Drug Administration, University of Michigan Health Interventional Radiologists Dr. David M. Williams and Dr. Minhaj S. Khaja successfully used VeinWay’s Traversa for venous recanalization to save a patient’s leg that was close to being amputated.